Abstract:Ubiquitin C-terminal hydrolase-L1 (UCH-L1), an important member of de-ubiquitination enzyme families involved in the ubiquitin-proteasome pathway, is expressed mainly in neural and reproductive systems as well as in some tumours. Recently, expression of UCH-L1 has been discovered in parietal epithelial cells of Bowman's capsules and some tubular epithelia in the kidney. However, whether UCH-L1 is expressed in the capillary tufts of the glomeruli has not yet become clear. In this study, we used immunohistochemistry, double immunofluorescence labelling, immunoelectron microscopy in kidney biopsy tissues and western blot in cultured rat podocytes to investigate the expression of UCH-L1 and the regulation of this expression in podocytes. The results demonstrated that UCH-L1 was expressed in podocytes and its expression was significantly higher in acute proliferative glomerulonephritis (APGN), lupus nephritis (LN), membranous glomerulonephritis (MGN) and IgA nephropathy than that in focal segmental glomeruloselerosis (FSGS), minimal change disease (MCD), minor abnormality and normal kidney tissues (p < 0.05). In in vitro experiments, western blot showed that UCH-L1 expression significantly increased in the two groups of podocytes co-cultured with mesangial cells exposed to ATS 50 mu l/ml and ATS 50 mu l/ml with normal human serum 30 mu l/ml, respectively (p < 0.05), while the other groups treated with TGF beta 1 1 ng/ml, TNF alpha 10 ng/ml or IL-1 10 ng/ml had little rise of UCH-L1 expression, with no statistical significance compared with normal control (P > 0.05). Further tests indicated that the percentage of PCNA-positive podocytes in LN, APGN and IgA nephropathy was significantly higher than that in MCD, FSGS and normal control (p < 0.05). These data show for the first time that podocytes do express UCH-L1 and that its expression can be increased in these immunocomplex-mediated nephrites. The immune injury is a main cause for stimulating podocytes to express UCH-L1. The expression of UCH-L1 may be associated with the regeneration of podocytes as a repair response to immunocomplex-mediated injury. Copyright (C) 2008 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Wnt / β-catenin pathway involved in podocyte injury is regulated by UCH-L 1

Wnt/Beta-Catenin Pathway Involved In Podocyte Injury Is Regulated By Uch-L1

Podocyte-specific deletion of ubiquitin carboxyl-terminal hydrolase L1 causes podocyte injury by inducing endoplasmic reticulum stress.

Calcineurin Inhibitors Ameliorate PAN‐induced Podocyte Injury Through the NFAT–Angptl4 Pathway

The Regulation of the UCH-L1 Gene by Transcription Factor NF-κB in Podocytes

The novel involvement of podocyte autophagic activity in the pathogenesis of lupus nephritis.

The Activation of Extracellular Signal-Regulated Kinase is Responsible for Podocyte Injury

Calcineurin inhibitors cyclosporin A and tacrolimus protect against podocyte injury induced by puromycin aminonucleoside in rodent models.

Liver X Receptor Activation Induces Podocyte Injury Via Inhibiting Autophagic Activity

NF‑κB upregulates ubiquitin C‑terminal hydrolase 1 in diseased podocytes in glomerulonephritis.

UCH-L1 Expression of Podocytes in Diseased Glomeruli and in Vitro.

MicroRNA-466o-3p mediates β-catenin-induced podocyte injury by targeting Wilms tumor 1

Metadherin orchestrates PKA and PKM2 to activate β-catenin signaling in podocytes during proteinuric chronic kidney disease

B7-1 mediates podocyte injury and glomerulosclerosis through communication with Hsp90ab1-LRP5-β-catenin pathway

Fractalkine is Involved in Lipopolysaccharide-Induced Podocyte Injury through the Wnt/β-Catenin Pathway in an Acute Kidney Injury Mouse Model

Hyperactivation of p53 contributes to mitotic catastrophe in podocytes through regulation of the Wee1/CDK1/cyclin B1 axis

Nuclear Receptor Interacting Protein-2 Mediates the Stabilization and Activation of Β-Catenin During Podocyte Injury.

Exogenous Wnt1 Prevents Acute Kidney Injury and Its Subsequent Progression to Chronic Kidney Disease

CCDC92 promotes podocyte injury by regulating PA28α/ABCA1/cholesterol efflux axis in type 2 diabetic mice

Defective CFTR Leads to Aberrant Β-Catenin Activation and Kidney Fibrosis

Upregulated LRRC55 Promotes BK Channel Activation and Aggravates Cell Injury in Podocytes